2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole
Structure Info
- Chemspace ID
- CSSB00010080903 (In-Stock Building Blocks)
- CAS
- 501944-79-2
- MFCD
- MFCD16988836, MFCD16988836
- IUPAC Name
- 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole
- Mol formula
- C15H18BNO3
- Mol weight
- 271 Da
- Catalog Number(s)
- 1121AJ, 165108, 32R0188P, A356101, A576402, AA00DJOT, ACENPW136, AG00DJRL, AG252602, AG31945, AKOS022177813, AR00DKGL, ArZ-UP353673, ArZ-UP357962, ArZ-UP370936, ArZ-UP500112, BB4LS-32R0188P, BB4LS-EN300-12600433, BBLS00010080903, BBV-82130249, BD211446, BVA94479, CD11115292, CS-0340351, CS-28786, CSC010080903, D636333, EC00DLXD, EN300-12600433, FCH2774704, HY-W295522, LAN-B57213, LN02219454, OR1142280, PI501944792, SAB-114484, ST00DL8D, T890453, TX00DKX9, Y1000882, Y1008879, Z2049757093, ZX-NM260612, ZXC078502, ZXC144072, ZXC215745, bbls00010080903
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.98
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.4
- Polar surface area (Å)
- 44
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole (C15H18BNO3) - CSSB00010080903](/st/structure/200/d7493e2fcfa6f58b083510d34aefbba5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%253DCO1.png "C15H18BNO3")
- Zoom the structure
- CSSB00010080903
Items Overall 62 items from 14 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 131.75 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 180.01 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 245.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 316.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 393.00 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 50 mg | 217.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 100 mg | 327.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 250 mg | 547.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 500 mg | 767.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 1 g | 1,097.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 5 g | 4,397.80 | |
Description: 2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-oxazole; CAS: 501944-79-2 | ||||||
| AiFChem | 5 days | United States To: | 97 | 100 mg | 198.00 | |
| AiFChem | 5 days | United States To: | 97 | 250 mg | 357.00 | |
| AiFChem | 5 days | United States To: | 97 | 1 g | 811.00 | |
Description: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; Hazard statement: H302, H315, H319, H335; CAS: 501944-79-2 | ||||||
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 268.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 400.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 572.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 902.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 1,157.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 2,268.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 3,355.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 4,974.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 50 mg | 268.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 100 mg | 400.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 250 mg | 572.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 500 mg | 902.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 1 g | 1,157.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 2.5 g | 2,268.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 268.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 400.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 572.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 902.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 1,157.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 2,268.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 5 g | 3,355.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 50 mg | 131.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 100 mg | 215.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 250 mg | 387.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 95 | 1 g | 880.00 | |
Description: Name:2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; CAS: 501944-79-2 | ||||||
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 131.75 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 180.01 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 245.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 316.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 393.00 | |
| AiFChem CN | 10 days | China To: | 97 | 50 mg | 121.00 | |
Description: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; Hazard statement: H302, H315, H319, H335; CAS: 501944-79-2 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 50 mg | 115.00 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 100 mg | 188.60 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 250 mg | 336.95 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 1 g | 767.05 | |
| Ambeed CN | 12 days | China To: | 95 | 50 mg | 117.90 | |
| Ambeed CN | 12 days | China To: | 95 | 100 mg | 193.50 | |
| Ambeed CN | 12 days | China To: | 95 | 250 mg | 348.30 | |
| Ambeed CN | 12 days | China To: | 95 | 1 g | 792.00 | |
Description: Name: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; CAS: 501944-79-2 | ||||||
| 1st Scientific CN | 14 days | China To: | 95 | 50 mg | 163.90 | |
| 1st Scientific CN | 14 days | China To: | 95 | 100 mg | 249.70 | |
| 1st Scientific CN | 14 days | China To: | 95 | 250 mg | 426.80 | |
| 1st Scientific CN | 14 days | China To: | 95 | 1 g | 935.00 | |
Description: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; CAS: 501944-79-2 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 95 | 50 mg | 112.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 100 mg | 183.70 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 250 mg | 326.70 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 1 g | 739.20 | |
Description: 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; CAS: 501944-79-2 | ||||||
| eNovation CN | 20 days | China To: | 95 | 5 g | 2,415.00 | |
Description: 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazole; CAS: 501944-79-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-benzoxazole - CSSB00020636813](/st/structure/200/5bc3c4cf6d37e24aac605cbd85877b24/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DCC%253DCC%253DC2O1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine - CSSB00015191782](/st/structure/200/80b23d7f41fc92eca3b764deeac83f6d/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DCC%253DCN%253DC2O1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-benzoxazol-6-amine - CSSB00121573075](/st/structure/200/45c1ec49ad0e3700191d728f41773b5e/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC2%253DCC%253DC%2528N%2529C%253DC2O1.png)
Similarity Analogs
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00010082543](/st/structure/200/29f6e0136a0a0e60951312cfcbefdbd9/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCO1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010246424](/st/structure/200/e935dfe232b4d585fec5d032ab406155/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB00021647921](/st/structure/200/f73f2db4851a2ae5a63956b43f1f8363/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DCSC%253DN1.png)
![Chemical structure of 3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2-oxazole - CSSB00010082541](/st/structure/200/e1e874b15fa68b1c2074251064a70a22/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%253DC1.png)
![Chemical structure of 5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00010082521](/st/structure/200/5bf87830f85f225eee5f6976b4fe22fd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DCN%253DCO1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB00010890257](/st/structure/200/172dc50805e157acd97558b9b47d9db6/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%253DCS1.png)
